Table of Contents

2019-2024 Global Healthcare Microfluidics Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Healthcare Microfluidics Consumption 2014-2024
  • 2.1.2 Healthcare Microfluidics Consumption CAGR by Region
• 2.2 Healthcare Microfluidics Segment by Type
  • 2.2.1 Glass Based
  • 2.2.2 Polymer Based
  • 2.2.3 Silicon Based
  • 2.2.4 Others
• 2.3 Healthcare Microfluidics Consumption by Type
  • 2.3.1 Global Healthcare Microfluidics Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Healthcare Microfluidics Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Healthcare Microfluidics Sale Price by Type (2014-2019)
• 2.4 Healthcare Microfluidics Segment by Application
  • 2.4.1 Homecare
  • 2.4.2 Hospitals
  • 2.4.3 Others
• 2.5 Healthcare Microfluidics Consumption by Application
  • 2.5.1 Global Healthcare Microfluidics Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Healthcare Microfluidics Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Healthcare Microfluidics Sale Price by Application (2014-2019)

3 Global Healthcare Microfluidics by Players

• 3.1 Global Healthcare Microfluidics Sales Market Share by Players
  • 3.1.1 Global Healthcare Microfluidics Sales by Players (2017-2019)
  • 3.1.2 Global Healthcare Microfluidics Sales Market Share by Players (2017-2019)
• 3.2 Global Healthcare Microfluidics Revenue Market Share by Players
  • 3.2.1 Global Healthcare Microfluidics Revenue by Players (2017-2019)
  • 3.2.2 Global Healthcare Microfluidics Revenue Market Share by Players (2017-2019)
• 3.3 Global Healthcare Microfluidics Sale Price by Players
• 3.4 Global Healthcare Microfluidics Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Healthcare Microfluidics Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Healthcare Microfluidics Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Healthcare Microfluidics by Regions

• 4.1 Healthcare Microfluidics by Regions
  • 4.1.1 Global Healthcare Microfluidics Consumption by Regions
  • 4.1.2 Global Healthcare Microfluidics Value by Regions
• 4.2 Americas Healthcare Microfluidics Consumption Growth
• 4.3 APAC Healthcare Microfluidics Consumption Growth
• 4.4 Europe Healthcare Microfluidics Consumption Growth
• 4.5 Middle East & Africa Healthcare Microfluidics Consumption Growth

5 Americas

• 5.1 Americas Healthcare Microfluidics Consumption by Countries
  • 5.1.1 Americas Healthcare Microfluidics Consumption by Countries (2014-2019)
  • 5.1.2 Americas Healthcare Microfluidics Value by Countries (2014-2019)
• 5.2 Americas Healthcare Microfluidics Consumption by Type
• 5.3 Americas Healthcare Microfluidics Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Healthcare Microfluidics Consumption by Countries
  • 6.1.1 APAC Healthcare Microfluidics Consumption by Countries (2014-2019)
  • 6.1.2 APAC Healthcare Microfluidics Value by Countries (2014-2019)
• 6.2 APAC Healthcare Microfluidics Consumption by Type
• 6.3 APAC Healthcare Microfluidics Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Healthcare Microfluidics by Countries
  • 7.1.1 Europe Healthcare Microfluidics Consumption by Countries (2014-2019)
  • 7.1.2 Europe Healthcare Microfluidics Value by Countries (2014-2019)
• 7.2 Europe Healthcare Microfluidics Consumption by Type
• 7.3 Europe Healthcare Microfluidics Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Healthcare Microfluidics by Countries
  • 8.1.1 Middle East & Africa Healthcare Microfluidics Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Healthcare Microfluidics Value by Countries (2014-2019)
• 8.2 Middle East & Africa Healthcare Microfluidics Consumption by Type
• 8.3 Middle East & Africa Healthcare Microfluidics Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Healthcare Microfluidics Distributors
• 10.3 Healthcare Microfluidics Customer

11 Global Healthcare Microfluidics Market Forecast

• 11.1 Global Healthcare Microfluidics Consumption Forecast (2019-2024)
• 11.2 Global Healthcare Microfluidics Forecast by Regions
  • 11.2.1 Global Healthcare Microfluidics Forecast by Regions (2019-2024)
  • 11.2.2 Global Healthcare Microfluidics Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Healthcare Microfluidics Forecast by Type
• 11.8 Global Healthcare Microfluidics Forecast by Application

12 Key Players Analysis

• 12.1 Abbott Laboratories
  • 12.1.1 Company Details
  • 12.1.2 Healthcare Microfluidics Product Offered
  • 12.1.3 Abbott Laboratories Healthcare Microfluidics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Abbott Laboratories News
• 12.2 Agilent Technologies, Inc.
  • 12.2.1 Company Details
  • 12.2.2 Healthcare Microfluidics Product Offered
  • 12.2.3 Agilent Technologies, Inc. Healthcare Microfluidics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Agilent Technologies, Inc. News
• 12.3 BD
  • 12.3.1 Company Details
  • 12.3.2 Healthcare Microfluidics Product Offered
  • 12.3.3 BD Healthcare Microfluidics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 BD News
• 12.4 Bio-Rad Laboratories
  • 12.4.1 Company Details
  • 12.4.2 Healthcare Microfluidics Product Offered
  • 12.4.3 Bio-Rad Laboratories Healthcare Microfluidics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Bio-Rad Laboratories News
• 12.5 Danaher Corporation
  • 12.5.1 Company Details
  • 12.5.2 Healthcare Microfluidics Product Offered
  • 12.5.3 Danaher Corporation Healthcare Microfluidics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Danaher Corporation News
• 12.6 Roche
  • 12.6.1 Company Details
  • 12.6.2 Healthcare Microfluidics Product Offered
  • 12.6.3 Roche Healthcare Microfluidics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Roche News
• 12.7 IDEX Corporation
  • 12.7.1 Company Details
  • 12.7.2 Healthcare Microfluidics Product Offered
  • 12.7.3 IDEX Corporation Healthcare Microfluidics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 IDEX Corporation News
• 12.8 PerkinElmer
  • 12.8.1 Company Details
  • 12.8.2 Healthcare Microfluidics Product Offered
  • 12.8.3 PerkinElmer Healthcare Microfluidics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 PerkinElmer News
• 12.9 Thermo Fisher Scientific
  • 12.9.1 Company Details
  • 12.9.2 Healthcare Microfluidics Product Offered
  • 12.9.3 Thermo Fisher Scientific Healthcare Microfluidics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 Thermo Fisher Scientific News

13 Research Findings and Conclusion

The field of microfluidics uses microfabrication to create miniaturized devices to handle fluids. The field of microfluidics has four parents: molecular analysis, biodefence, molecular biology and microelectronics. Advances in microfluidics technology are revolutionizing molecular biology procedures for enzymatic analysis (glucose and lactate assays), DNA analysis (polymerase chain reaction and high-throughput sequencing), and proteomics.

According to this study, over the next five years the Healthcare Microfluidics market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Healthcare Microfluidics business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Healthcare Microfluidics market by product type, application, key manufacturers and key regions and countries.

This study considers the Healthcare Microfluidics value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Glass Based
Polymer Based
Silicon Based
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Homecare
Hospitals
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Abbott Laboratories
Agilent Technologies, Inc.
BD
Bio-Rad Laboratories
Danaher Corporation
Roche
IDEX Corporation
PerkinElmer
Thermo Fisher Scientific

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Healthcare Microfluidics consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Healthcare Microfluidics market by identifying its various subsegments.
Focuses on the key global Healthcare Microfluidics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Healthcare Microfluidics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Healthcare Microfluidics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.